Nanda Horeweg

23PUBLICATIONS
79CO-AUTHORS
Social epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Stochastic analysis and modellingPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 19, 2026
Prognostic Relevance of Molecular Classification in Endometrial Cancer: Insights From a South African Cohort.

Rubina Razack, Ezgi Dicle Serbes, Michelle Cara Bryan-Mc Innes

|Apr 23, 2025
Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands.

Aryana Shirzada, Arwen H Pieterse, Lisa Vlug

|Mar 05, 2025
Analyzing Coarsened and Missing Data by Imputation Methods.

Lars L J van der Burg, Stefan Böhringer, Jonathan W Bartlett

|Oct 07, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.

Dione van Dijk, Lisa Vermij, Alicia León-Castillo

|May 24, 2024
Prediction of recurrence risk in endometrial cancer with multimodal deep learning.

Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani

|Apr 24, 2024
Prognostic value of molecular classification in stage IV endometrial cancer.

Margot H Uijterwaal, Dione van Dijk, Christianne A R Lok

Pageof 4

Frequent Collaborators

9 joint publications

Carien L Creutzberg

7 joint publications

Tjalling Bosse

5 joint publications

Lisa Vermij

4 joint publications

Jan Jobsen